Item 2.02 Results of Operations and Financial Condition.
On
Item 7.01 Regulation FD Disclosure.
In addition to the matters addressed in Item 2.02, the Letter to Shareholders discussed product orders, advancements made in certain key products in the Company's research and development pipeline, and certain other matters.
In accordance with General Instruction B.2 of Form 8-K, the information in Item 2.02 and Item 7.01, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits Exhibit Number Description 99.1 Letter to Shareholders datedJanuary 18, 2022 .
© Edgar Online, source